205 related articles for article (PubMed ID: 6419593)
21. Auranofin in the treatment of juvenile rheumatoid arthritis.
Giannini EH; Brewer EJ; Person DA
J Pediatr; 1983 Jan; 102(1):138-41. PubMed ID: 6401327
[TBL] [Abstract][Full Text] [Related]
22. Proteinuria in gold-treated rheumatoid arthritis.
Katz WA; Blodgett RC; Pietrusko RG
Ann Intern Med; 1984 Aug; 101(2):176-9. PubMed ID: 6430141
[TBL] [Abstract][Full Text] [Related]
23. A single-blind comparative study of auranofin and hydroxychloroquine in patients with rheumatoid arthritis.
Bird HA; Le Gallez P; Dixon JS; Surrall KE; Cole DS; Goldman MH; Wright V
Clin Rheumatol; 1984 Mar; 3 Suppl 1():57-66. PubMed ID: 6432415
[TBL] [Abstract][Full Text] [Related]
24. Oral gold therapy with auranofin (SK&F 39162). A multicenter open study in patients with rheumatoid arthritis.
Bandilla K; Gross D; Gross W; Herrlinger JD; Kriegel W; Müller W; Siegmeth W; Tausch G; Thumb N; Wagenhäuser FJ
J Rheumatol Suppl; 1982; 8():154-9. PubMed ID: 6813478
[TBL] [Abstract][Full Text] [Related]
25. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
[TBL] [Abstract][Full Text] [Related]
26. Auranofin: dose-related risk to benefit.
Weiss TE
Am J Med; 1983 Dec; 75(6A):128-32. PubMed ID: 6419594
[TBL] [Abstract][Full Text] [Related]
27. Longterm experience with oral gold in rheumatoid arthritis and psoriatic arthritis.
Dequeker J; Verdickt W; Gevers G; Vanschoubroek K
Clin Rheumatol; 1984 Mar; 3 Suppl 1():67-74. PubMed ID: 6432416
[TBL] [Abstract][Full Text] [Related]
28. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
Coughlan RJ; Richter MB; Panayi GS
Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
[TBL] [Abstract][Full Text] [Related]
29. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
Bernhard GC
J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
[TBL] [Abstract][Full Text] [Related]
30. An oral gold formulation in rheumatoid arthritis. A 12-month follow-up report.
Schorn D
S Afr Med J; 1982 Aug; 62(10):313-6. PubMed ID: 6810477
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
Rainer F; Ulreich A
Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
[No Abstract] [Full Text] [Related]
32. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
33. Interim results of a multicenter open study with auranofin in Japan.
Homma M; Abe T; Akizuki M; Shiokawa Y; Shichikawa K; Kageyama T; Yoshizawa H; Azuma T; Mizushima Y; Okazaki T; Sugawara S
J Rheumatol Suppl; 1982; 8():160-8. PubMed ID: 6813479
[TBL] [Abstract][Full Text] [Related]
34. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE
Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
[TBL] [Abstract][Full Text] [Related]
35. Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo.
Gofton JP; O'Brien WM; Hurley JN; Scheffler BJ
J Rheumatol; 1984 Dec; 11(6):768-71. PubMed ID: 6440982
[TBL] [Abstract][Full Text] [Related]
36. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
Horton RJ
Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
[TBL] [Abstract][Full Text] [Related]
37. Roentgenographic findings during auranofin treatment.
Gofton JP; O'Brien W
Am J Med; 1983 Dec; 75(6A):142-4. PubMed ID: 6419597
[TBL] [Abstract][Full Text] [Related]
38. Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
Dahl SL; Coleman ML; Williams HJ; Altz-Smith M; Kay DR; Paulus HE; Weinstein A; Kaplan S
Arthritis Rheum; 1985 Nov; 28(11):1211-8. PubMed ID: 3933523
[TBL] [Abstract][Full Text] [Related]
39. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis.
Davies J; Bacon PA; Hall ND; Ring EF
Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670
[No Abstract] [Full Text] [Related]
40. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis.
Larsen A; Horton J; Howland C
Clin Rheumatol; 1984 Mar; 3 Suppl 1():97-104. PubMed ID: 6432419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
